0.0010
0.0000
(0.00%)
As of January 30 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,738.0000
-1,687.0000
-1,698.0000
-1,696.0000
Investing Cash Flow
94.0000
-2.0000
-10.0000
-14.0000
Financing Cash Flow
1,322.0000
1,436.0000
1,200.0000
2,106.0000
End Cash Position
79.0000
313.0000
571.0000
1,083.0000
Income Tax Paid Supplemental Data
--
--
--
15.0000
Capital Expenditure
--
-2.0000
-10.0000
-14.0000
Issuance of Debt
1,350.0000
1,450.0000
1,200.0000
2,106.0000
Repayment of Debt
-28.0000
-14.0000
--
--
Free Cash Flow
-1,738.0000
-1,689.0000
-1,708.0000
-1,710.0000
12/31/2020 - 10/26/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EMMA Emmaus Life Sciences, Inc.
0.0163
0.00%
PKTX ProtoKinetix, Incorporated
0.0095
-5.00%
GSTC GlobeStar Therapeutics Corporation
0.0003
0.00%
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0011
0.00%
PPCBD Propanc Biopharma, Inc.
11.00
+10.00%
AXIM AXIM Biotechnologies, Inc.
0.0040
0.00%
TXTM ProText Mobility, Inc.
0.0009
0.00%
PVCT Provectus Biopharmaceuticals, Inc.
0.1090
-0.91%
RGBP Regen BioPharma, Inc.
0.0621
0.00%